At 11.5% CAGR, Asia Pacific Laser-Assisted ENT Surgery Market is Projected to be Worth US$ 1,17,988.30 Thousand by 2031, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific laser-assisted ENT surgery market was valued at US$ 49,406.24 thousand in 2023 and is expected to reach US$ 1,17,988.30 thousand by 2031, registering a CAGR of 11.5% from 2023 to 2031. Growing demand for outpatient procedures and increasing prevalence of ENT disorders are among the critical factors attributed to drive the Asia Pacific laser-assisted ENT surgery market growth.

As healthcare systems worldwide increasingly prioritize outpatient care, the landscape of surgical interventions is evolving, with laser-assisted surgeries emerging as a preferred option for many ENT conditions. This shift is driven by several factors, including advancements in medical technology, patient preferences for convenience and reduced recovery times, and the economic benefits of outpatient procedures. Lasers, such as carbon dioxide (CO₂) lasers and Nd: YAG lasers, are widely used in various ENT surgeries, including the treatment of chronic sinusitis, tonsillectomies, and the removal of tumors. These lasers allow for precise tissue targeting, minimizing damage to surrounding areas and significantly reducing postoperative complications. As a result, many procedures that once required hospitalization can now be performed in outpatient settings, aligning with the growing preference for minimally invasive techniques. Patients are increasingly seeking outpatient procedures due to the numerous advantages they offer. Outpatient surgeries typically involve shorter recovery times, allowing patients to return to their daily activities more quickly. This is particularly appealing in the fast-paced world, where individuals are often reluctant to take extended time off work or disrupt their personal lives for medical procedures. Laser-assisted surgeries, with their reduced recovery periods and lower risk of complications, fit perfectly into this demand. Patients appreciate the ability to undergo treatment and return home the same day, which enhances their overall experience and satisfaction with the healthcare system. Furthermore, the shift toward outpatient procedures is influenced by changes in healthcare policies and reimbursement models. Many insurance providers now favor outpatient surgeries due to their cost-effectiveness and positive patient outcomes. This shift in reimbursement strategies encourages healthcare providers to adopt laser-assisted techniques, as they can offer high-quality care while meeting the financial incentives set forth by insurers. As reimbursement policies evolve, the laser-assisted ENT surgery market will likely benefit from increased adoption and utilization of these procedures. As a result, the growing demand for outpatient procedures positively impacts the laser-assisted ENT surgery market.

On the contrary, the high costs of equipment hamper the growth of Asia Pacific laser-assisted ENT surgery market.

Based on laser type, the Asia Pacific laser-assisted ENT surgery market is segmented into CO2laser, Nd.YAGlaser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO2laser segment held 43.5% market share in 2023, amassing US$ 21,492.22 thousand. It is projected to garner US$ 51,928.81 thousand by 2031 to register 11.7% CAGR during 2023–2031.

In terms of surgery type, the Asia Pacific laser-assisted ENT surgery market is divided into laser laryngeal surgery, laser endoscopic sinus surgery (LESS), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinate reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held 32.0% share of Asia Pacific laser-assisted ENT surgery market in 2023, amassing US$ 15,808.80 thousand. It is anticipated to garner US$ 39,925.78 thousand by 2031 to expand at 12.3% CAGR during 2023–2031.

By end user, the Asia Pacific laser-assisted ENT surgery market is categorized into hospitals and specialty clinics, physician office, and other end-users. The hospitals and specialty clinics segment held 60.9% share of Asia Pacific laser-assisted ENT surgery market in 2023, amassing US$ 30,079.35 thousand. It is projected to garner US$ 75,690.45 thousand by 2031 to expand at 12.2% CAGR from 2023 to 2031.

Based on country, the Asia Pacific laser laser-assisted ENT surgery market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.8% share of Asia Pacific laser-assisted ENT surgery market in 2023. It was assessed at US$ 13,751.60 thousand in 2023 and is likely to hit US$ 34,725.48 thousand by 2031, registering a CAGR of 12.3% during 2023–2031.

Key players operating in the laser-assisted ENT surgery market are biolitec AG (Biolitec); Iridex Corporation; Medency; Dimed Laser Technology Co., Ltd.; intros Medical Laser GmbH; ARC Laser GmbH; LightScalpel; GIGAAMEDICAL; INTERmedic ARFRAN; Limmer Laser GmbH; Qolight Medical Laser; and Sisram Medical Ltd., among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com